Résultats de re-traitement pipeline v2 sur 261 dossiers. Co-Authored-By: Claude Opus 4.6 <noreply@anthropic.com>
345 lines
13 KiB
JSON
345 lines
13 KiB
JSON
{
|
||
"source_file": "trackare-BA132287-23104930_BA132287_23104930.pdf",
|
||
"document_type": "trackare",
|
||
"sejour": {
|
||
"sexe": "M",
|
||
"age": 58,
|
||
"date_entree": "12/06/2023",
|
||
"date_sortie": "16/06/2023",
|
||
"duree_sejour": 4,
|
||
"imc": 45.0,
|
||
"poids": 155.0,
|
||
"taille": 185.0
|
||
},
|
||
"diagnostic_principal": {
|
||
"texte": "Obésité (IMC 45.464)",
|
||
"cim10_suggestion": "E66.0",
|
||
"cim10_confidence": "high",
|
||
"cim10_final": "E66.0",
|
||
"cim10_decision": {
|
||
"action": "PROMOTE_DP",
|
||
"final_code": "E66.0",
|
||
"reason": "DAS promu en DP (score (2, 3, 4))",
|
||
"needs_info": [],
|
||
"applied_rules": [
|
||
"RULE-DAS-TO-DP"
|
||
]
|
||
},
|
||
"sources_rag": [],
|
||
"preuves_cliniques": [],
|
||
"source": "regex"
|
||
},
|
||
"dp_final": {
|
||
"verdict": "REVIEW",
|
||
"evidence": [],
|
||
"reason": "Aucun DP disponible",
|
||
"candidates": []
|
||
},
|
||
"quality_flags": {
|
||
"rag_status": "error",
|
||
"no_dp_source": true
|
||
},
|
||
"diagnostics_associes": [
|
||
{
|
||
"texte": "Hypertension artérielle",
|
||
"cim10_suggestion": "I10",
|
||
"cim10_confidence": "high",
|
||
"cim10_final": "I10",
|
||
"sources_rag": [],
|
||
"preuves_cliniques": [],
|
||
"niveau_severite": "non_evalue",
|
||
"niveau_cma": 1,
|
||
"source": "regex"
|
||
},
|
||
{
|
||
"texte": "Diabète de type 2",
|
||
"cim10_suggestion": "E11.9",
|
||
"cim10_confidence": "medium",
|
||
"cim10_final": "E11.9",
|
||
"sources_rag": [],
|
||
"preuves_cliniques": [],
|
||
"est_cma": true,
|
||
"niveau_severite": "non_evalue",
|
||
"niveau_cma": 2,
|
||
"source": "regex",
|
||
"source_page": 4,
|
||
"source_excerpt": "...sols de\nBDCA, permettant une évolution favorable et un sevrage en O2.\nSynthèse de l’hospitalisation\nDiabète de type 2 dont l'équilibre s'est amélioré, HbA1c 7.5%. Optimisation du traitement par\najout de FORXIGA. Propo..."
|
||
},
|
||
{
|
||
"texte": "Dyslipidémie",
|
||
"cim10_suggestion": "E78.5",
|
||
"cim10_confidence": "low",
|
||
"cim10_final": "E78.5",
|
||
"sources_rag": [],
|
||
"preuves_cliniques": [],
|
||
"niveau_severite": "non_evalue",
|
||
"niveau_cma": 1,
|
||
"source": "regex",
|
||
"source_page": 3,
|
||
"source_excerpt": "...Semaine d'éducation thérapeutique de diabétologie\nAntécédents/Maladie en cours\nDiabète\nObésité\nHTA\nDyslipidémie\nSAS appareillé\nMaladie de Crohn\nMGUS à IgA suivi Dr Robin\nSleeve gastrectomie en 2006 et 2018\nChiru..."
|
||
}
|
||
],
|
||
"actes_ccam": [],
|
||
"antecedents": [],
|
||
"traitements_sortie": [],
|
||
"biologie_cle": [
|
||
{
|
||
"test": "ASAT",
|
||
"valeur": "17",
|
||
"valeur_num": 17.0,
|
||
"anomalie": false,
|
||
"quality": "ok",
|
||
"source_page": 3,
|
||
"source_excerpt": "...138 K 4.9 Ch 100 mmol/l\nNFS normale\nAcide urique normal\nCréatinine 88.4 umol/l soit DFG 82.6 ml/min\nASAT 17 U/L, ALAT 13 U/L, GGT 20 U/L\nTG 1.19 g/l, HDL 0.37 g/L, LDL 0.43 g/l\nTSH normale 1.17 mU/L\nPSA n..."
|
||
},
|
||
{
|
||
"test": "ALAT",
|
||
"valeur": "13",
|
||
"valeur_num": 13.0,
|
||
"anomalie": false,
|
||
"quality": "ok",
|
||
"source_page": 3,
|
||
"source_excerpt": "...100 mmol/l\nNFS normale\nAcide urique normal\nCréatinine 88.4 umol/l soit DFG 82.6 ml/min\nASAT 17 U/L, ALAT 13 U/L, GGT 20 U/L\nTG 1.19 g/l, HDL 0.37 g/L, LDL 0.43 g/l\nTSH normale 1.17 mU/L\nPSA normal\nUrines..."
|
||
},
|
||
{
|
||
"test": "GGT",
|
||
"valeur": "20",
|
||
"valeur_num": 20.0,
|
||
"anomalie": false,
|
||
"quality": "ok",
|
||
"source_page": 3,
|
||
"source_excerpt": "...S normale\nAcide urique normal\nCréatinine 88.4 umol/l soit DFG 82.6 ml/min\nASAT 17 U/L, ALAT 13 U/L, GGT 20 U/L\nTG 1.19 g/l, HDL 0.37 g/L, LDL 0.43 g/l\nTSH normale 1.17 mU/L\nPSA normal\nUrines : rapport al..."
|
||
},
|
||
{
|
||
"test": "Sodium",
|
||
"valeur": "138",
|
||
"valeur_num": 138.0,
|
||
"anomalie": false,
|
||
"quality": "ok",
|
||
"source_page": 16,
|
||
"source_excerpt": "...s 4,27 10.12/l (t/l)\nHémoglobine 13,9 g/dl\nVGM 95,3 fl\nTCMH 32,6 pg\nCCMH 34,2 g/dl\nNon conformité :\nSodium Absence de tube\nhépariné mmol/l\nRefus (analyse(s)\nDécision non conformité 1\nannulée(s))\nAbsence de..."
|
||
},
|
||
{
|
||
"test": "Potassium",
|
||
"valeur": "4.9",
|
||
"valeur_num": 4.9,
|
||
"anomalie": false,
|
||
"quality": "ok",
|
||
"source_page": 16,
|
||
"source_excerpt": "...uine\nXN (Sysmex)\nHématocrite (%) 40,7 %\nIndice de distribution des\n13,9 %\nhématies\nNon conformité :\nPotassium Absence de tube\nhépariné mmol/l\nPCR Grippe A Négative\nPCR Grippe B Négative\nPCR COVID 19 (prélèveme..."
|
||
},
|
||
{
|
||
"test": "Hémoglobine",
|
||
"valeur": "13.9",
|
||
"valeur_num": 13.9,
|
||
"anomalie": false,
|
||
"quality": "ok",
|
||
"source_page": 6,
|
||
"source_excerpt": "...n lipidique ( cholestérol total,\n12/06/2023 08:00 Camille Marie MAJCHRZAK\ntriglycérides, HDL, LDL )\nHémoglobine glycosylée HbA1C\n12/06/2023 08:00 Camille Marie MAJCHRZAK\n( dosage )\n12/06/2023 08:00 Protéines dos..."
|
||
},
|
||
{
|
||
"test": "VGM",
|
||
"valeur": "95.3",
|
||
"valeur_num": 95.3,
|
||
"quality": "ok",
|
||
"source_page": 16,
|
||
"source_excerpt": "...ure\npolymicrobienne)\nLeucocytes 5,87 10.9/l 4 /µL\nHématies 4,27 10.12/l (t/l)\nHémoglobine 13,9 g/dl\nVGM 95,3 fl\nTCMH 32,6 pg\nCCMH 34,2 g/dl\nNon conformité :\nSodium Absence de tube\nhépariné mmol/l\nRefus (..."
|
||
},
|
||
{
|
||
"test": "Plaquettes",
|
||
"valeur": "197",
|
||
"valeur_num": 197.0,
|
||
"anomalie": false,
|
||
"quality": "ok",
|
||
"source_page": 16,
|
||
"source_excerpt": "...analyse(s)\nDécision non conformité 1\nannulée(s))\nAbsence de tube\nMotif de non conformité 1\nhépariné\nPlaquettes 197 10.9/l\nLe patient est-il professionel\nnon\nde santé ?\nValidation et diffusion sous la Dr. Fanny..."
|
||
},
|
||
{
|
||
"test": "Leucocytes",
|
||
"valeur": "5.87",
|
||
"valeur_num": 5.87,
|
||
"anomalie": false,
|
||
"quality": "ok",
|
||
"source_page": 16,
|
||
"source_excerpt": "...Standard Urine Milieu de jet\nPrésence de plus de\nCulture ECBU TK 2 germes (culture\npolymicrobienne)\nLeucocytes 5,87 10.9/l 4 /µL\nHématies 4,27 10.12/l (t/l)\nHémoglobine 13,9 g/dl\nVGM 95,3 fl\nTCMH 32,6 pg\nCCMH 3..."
|
||
},
|
||
{
|
||
"test": "Créatinine",
|
||
"valeur": "88.4",
|
||
"valeur_num": 88.4,
|
||
"anomalie": false,
|
||
"quality": "ok",
|
||
"source_page": 3,
|
||
"source_excerpt": "...ogique en externe du 24/05/23\nHbA1c 7.5%\nNa 138 K 4.9 Ch 100 mmol/l\nNFS normale\nAcide urique normal\nCréatinine 88.4 umol/l soit DFG 82.6 ml/min\nASAT 17 U/L, ALAT 13 U/L, GGT 20 U/L\nTG 1.19 g/l, HDL 0.37 g/L, LD..."
|
||
},
|
||
{
|
||
"test": "Glycémie",
|
||
"valeur": "1.45",
|
||
"valeur_num": 1.45,
|
||
"anomalie": true,
|
||
"quality": "ok",
|
||
"source_page": 1,
|
||
"source_excerpt": ".../06/2023\nsurveillance 08:36 08:33 22:12 19:10 14:38 12:57 09:03 22:17 19:19 18:26 14:36 14:12 12:39\nGlycémie\n1,45 1,35 1,56 1,32 1,72 1,31 1,61 1,23 1,58 1,33\ncapillaire\nTempérature 36,60 36,70 36,40\nPouls 92..."
|
||
},
|
||
{
|
||
"test": "HbA1c",
|
||
"valeur": "7.5",
|
||
"valeur_num": 7.5,
|
||
"anomalie": true,
|
||
"quality": "ok",
|
||
"source_page": 3,
|
||
"source_excerpt": "...arents DT2\ntraitement par Metformine et trulicity (majoration à 4.5mg depuis environ 1 an)\nDernière HbA1c en mai 2023 7.5%\nHistoire de la Camille Marie 12/06/2023\nRetentissement :\nmaladie MAJCHRZAK 11:53\nF..."
|
||
},
|
||
{
|
||
"test": "HbA1c",
|
||
"valeur": "1",
|
||
"valeur_num": 1.0,
|
||
"anomalie": true,
|
||
"quality": "discarded",
|
||
"discard_reason": "Valeur hors bornes plausibles (<2)",
|
||
"source_page": 3,
|
||
"source_excerpt": "...arents DT2\ntraitement par Metformine et trulicity (majoration à 4.5mg depuis environ 1 an)\nDernière HbA1c en mai 2023 7.5%\nHistoire de la Camille Marie 12/06/2023\nRetentissement :\nmaladie MAJCHRZAK 11:53\nF..."
|
||
}
|
||
],
|
||
"biologie_discarded": [],
|
||
"imagerie": [],
|
||
"complications": [
|
||
{
|
||
"texte": "Infection",
|
||
"source_page": 4,
|
||
"source_excerpt": "...slipidémie). Le patient y est favorable, et\nsera recontacté pour organiser la mise sous traitement.\nInfection respiratoire :\nA l'arrivée en hospitalisation : toux grasse depuis 24-48h, sans DRA ni désaturation..."
|
||
}
|
||
],
|
||
"alertes_codage": [
|
||
"QUALITE DEGRADEE : erreur RAG — codage sans référentiels",
|
||
"CMA niveau 2 : 'Diabète de type 2' (E11.9) — sévérité non_evalue",
|
||
"QC: DAS I10 (Hypertension artérielle) à reconsidérer — Aucune preuve d'hypertension artérielle dans le dossier. Le codage est injustifié.",
|
||
"QC: L'absence de justification pour plusieurs codes DAS est un problème majeur. La justification est un élément essentiel du codage PMSI.",
|
||
"QC: L'HbA1c présente deux valeurs différentes (7.5 et 1). Il est impératif de vérifier la source de cette information et de corriger l'erreur.",
|
||
"QC: Le dossier clinique est incomplet. Des informations supplémentaires, notamment concernant les antécédents du patient et les résultats des analyses lipidiques, seraient utiles pour un codage plus précis.",
|
||
"RULE-DAS-TO-DP: DP absent → DAS E66.0 (Obésité (IMC 45.464)) promu en DP",
|
||
"DECISIONS[PDF]: 1 ligne(s)",
|
||
"DECISION: diagnostic_principal E66.0 promu en DP (RULE-DAS-TO-DP)",
|
||
"VETOS[PDF]: NEED_INFO (score=70)",
|
||
"VETO-02 [MEDIUM] diagnostics_associes[0]: DAS I10 sans preuve exploitable",
|
||
"VETO-02 [MEDIUM] diagnostics_associes[3]: DAS E66.0 sans preuve exploitable",
|
||
"Aucun DP extrait (ni Trackare ni CRH)"
|
||
],
|
||
"source_files": [],
|
||
"ghm_estimation": {
|
||
"cmd": "10",
|
||
"cmd_libelle": "Maladies endocriniennes",
|
||
"type_ghm": "M",
|
||
"severite": 2,
|
||
"ghm_approx": "10M??2",
|
||
"cma_count": 1,
|
||
"cms_count": 0,
|
||
"alertes": []
|
||
},
|
||
"controles_cpam": [],
|
||
"veto_report": {
|
||
"verdict": "NEED_INFO",
|
||
"score_contestabilite": 70,
|
||
"issues": [
|
||
{
|
||
"veto": "VETO-02",
|
||
"severity": "MEDIUM",
|
||
"where": "diagnostics_associes[0]",
|
||
"message": "DAS I10 sans preuve exploitable",
|
||
"citation": "Principe de preuve : tout diagnostic/acte doit être étayé par une trace dans le dossier médical (Guide Méthodologique MCO)"
|
||
},
|
||
{
|
||
"veto": "VETO-02",
|
||
"severity": "MEDIUM",
|
||
"where": "diagnostics_associes[3]",
|
||
"message": "DAS E66.0 sans preuve exploitable",
|
||
"citation": "Principe de preuve : tout diagnostic/acte doit être étayé par une trace dans le dossier médical (Guide Méthodologique MCO)"
|
||
}
|
||
]
|
||
},
|
||
"completude": {
|
||
"checks": [
|
||
{
|
||
"code": "E66.0",
|
||
"libelle": "Obésité (IMC 45.464)",
|
||
"type_diag": "DP",
|
||
"items": [
|
||
{
|
||
"categorie": "clinique",
|
||
"element": "IMC",
|
||
"statut": "present_confirme",
|
||
"valeur": "45.0",
|
||
"importance": "obligatoire",
|
||
"impact_cpam": "IMC ≥ 30 indispensable pour coder une obésité",
|
||
"confirmation_detail": "IMC ≥ 30 confirme l'obésité"
|
||
},
|
||
{
|
||
"categorie": "clinique",
|
||
"element": "Poids",
|
||
"statut": "present",
|
||
"valeur": "155.0",
|
||
"importance": "obligatoire",
|
||
"impact_cpam": "Poids nécessaire pour calculer l'IMC"
|
||
}
|
||
],
|
||
"score": 100,
|
||
"verdict": "defendable",
|
||
"resume": "2/2 obligatoires (1 confirmé)"
|
||
},
|
||
{
|
||
"code": "E11.9",
|
||
"libelle": "Diabète de type 2",
|
||
"type_diag": "DAS",
|
||
"items": [
|
||
{
|
||
"categorie": "biologie",
|
||
"element": "HbA1c",
|
||
"statut": "present",
|
||
"valeur": "13.9",
|
||
"importance": "recommande",
|
||
"impact_cpam": "HbA1c attendue pour documenter l'équilibre glycémique"
|
||
},
|
||
{
|
||
"categorie": "biologie",
|
||
"element": "Glycémie",
|
||
"statut": "present",
|
||
"valeur": "1.45",
|
||
"importance": "recommande",
|
||
"impact_cpam": "Glycémie de base pour confirmer le diagnostic"
|
||
}
|
||
],
|
||
"score": 100,
|
||
"verdict": "defendable",
|
||
"resume": "2/2 recommandés"
|
||
}
|
||
],
|
||
"score_global": 100,
|
||
"verdict_global": "defendable",
|
||
"documents_presents": [
|
||
"trackare"
|
||
],
|
||
"documents_manquants": []
|
||
},
|
||
"processing_time_s": 852.62,
|
||
"metrics": {
|
||
"das_total": 3,
|
||
"das_active": 3,
|
||
"das_excluded": 0,
|
||
"das_removed": 0,
|
||
"das_ruled_out": 0,
|
||
"das_no_code": 0,
|
||
"actes_total": 0,
|
||
"actes_with_code": 0,
|
||
"dp_has_code": true
|
||
},
|
||
"rules_runtime": {
|
||
"router_version": 1,
|
||
"mode": "strict",
|
||
"enabled_packs": [
|
||
"decisions_core",
|
||
"vetos_core"
|
||
],
|
||
"always_on_rules": [],
|
||
"triggers_fired": []
|
||
}
|
||
} |